220 related articles for article (PubMed ID: 31221372)
41. The Statistical Fragility of Foot and Ankle Surgery Randomized Controlled Trials.
Milto AJ; Negri CE; Baker J; Thuppal S
J Foot Ankle Surg; 2023; 62(1):191-196. PubMed ID: 36182644
[TBL] [Abstract][Full Text] [Related]
42. Pulmonary arterial hypertension trials put to the test: Using the fragility index to assess trials robustness.
Garcia MVF; Coz-Yataco A; Al-Jaghbeer MJ
Heart Lung; 2023; 61():147-152. PubMed ID: 37271106
[TBL] [Abstract][Full Text] [Related]
43. The Number of Patients Lost to Follow-Up May Exceed the Fragility Index of a Randomized Controlled Trial Without Reversing Statistical Significance: A Systematic Review and Statistical Model.
Oeding JF; Krych AJ; Camp CL; Varady NH
Arthroscopy; 2024 May; ():. PubMed ID: 38777001
[TBL] [Abstract][Full Text] [Related]
44. The Fragility Index in Randomized Clinical Trials as a Means of Optimizing Patient Care.
Tignanelli CJ; Napolitano LM
JAMA Surg; 2019 Jan; 154(1):74-79. PubMed ID: 30422256
[TBL] [Abstract][Full Text] [Related]
45. Statistical fragility of randomized clinical trials in shoulder arthroplasty.
McCormick KL; Tedesco LJ; Swindell HW; Forrester LA; Jobin CM; Levine WN
J Shoulder Elbow Surg; 2021 Aug; 30(8):1787-1793. PubMed ID: 33271323
[TBL] [Abstract][Full Text] [Related]
46. Fragility index of trials supporting approval of anti-cancer drugs in common solid tumours.
Desnoyers A; Wilson BE; Nadler MB; Amir E
Cancer Treat Rev; 2021 Mar; 94():102167. PubMed ID: 33652263
[TBL] [Abstract][Full Text] [Related]
47. Statistical robustness of randomized controlled trials in high-impact journals has improved but was low across medical specialties.
Kampman JM; Turgman O; Sperna Weiland NH; Hollmann MW; Repping S; Hermanides J
J Clin Epidemiol; 2022 Oct; 150():165-170. PubMed ID: 35820586
[TBL] [Abstract][Full Text] [Related]
48. Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002-2022).
Sidali S; Sritharan N; Campani C; Gregory J; Durand F; Ganne-Carrié N; Ronot M; Lévy V; Nault JC
JHEP Rep; 2023 Jul; 5(7):100755. PubMed ID: 37425214
[TBL] [Abstract][Full Text] [Related]
49. The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review.
Proal JD; Moon AS; Kwon B
Eur Spine J; 2024 May; ():. PubMed ID: 38802596
[TBL] [Abstract][Full Text] [Related]
50. The fragility index in randomized clinical trials supporting clinical practice guidelines for acute coronary syndrome: measuring robustness from a different perspective.
Gonzalez-Del-Hoyo M; Mas-Llado C; Blaya-Peña L; Siquier-Padilla J; Peral V; Rossello X
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):386-390. PubMed ID: 36882068
[TBL] [Abstract][Full Text] [Related]
51. How robust are clinical trials in heart failure?
Docherty KF; Campbell RT; Jhund PS; Petrie MC; McMurray JJV
Eur Heart J; 2017 Feb; 38(5):338-345. PubMed ID: 27742808
[TBL] [Abstract][Full Text] [Related]
52. The fragility of statistical significance in distal femur fractures: systematic review of randomized controlled trials.
Megafu M; Mian H; Megafu E; Singhal S; Lee A; Cassie R; Tornetta P; Parisien R
Eur J Orthop Surg Traumatol; 2023 Aug; 33(6):2411-2418. PubMed ID: 36461949
[TBL] [Abstract][Full Text] [Related]
53. The Statistical Fragility of Single-Bundle vs Double-Bundle Autografts for ACL Reconstruction: A Systematic Review of Comparative Studies.
Ehlers CB; Curley AJ; Fackler NP; Minhas A; Rodriguez AN; Pasko K; Chang ES
Orthop J Sports Med; 2021 Dec; 9(12):23259671211064626. PubMed ID: 34988239
[TBL] [Abstract][Full Text] [Related]
54. Urologic oncology randomized controlled trials are frequently fragile - A review of the urology literature.
Chertin L; Burman I; Haifler M
Urol Oncol; 2021 Oct; 39(10):735.e1-735.e8. PubMed ID: 34103225
[TBL] [Abstract][Full Text] [Related]
55. Fragility index: how fragile is the data that support the American College of Gastroenterology guidelines for the management of Crohn's disease?
Majeed M; Agrawal R; Attar BM; Kamal S; Patel P; Omar YA; Demetria M; Agrawal P; Gandhi S
Eur J Gastroenterol Hepatol; 2020 Feb; 32(2):193-198. PubMed ID: 31851082
[TBL] [Abstract][Full Text] [Related]
56. Fragility of randomized clinical trials of treatment of clavicular fractures.
Ruzbarsky JJ; Khormaee S; Rauck RC; Warren RF
J Shoulder Elbow Surg; 2019 Mar; 28(3):415-422. PubMed ID: 30771826
[TBL] [Abstract][Full Text] [Related]
57. Analysis of Robustness of the Landmark Cardiovascular Outcome Trials of Antidiabetic Drugs - A Systematic Review.
Bose D; Konwar M
Curr Diabetes Rev; 2022; 18(6):e140921196472. PubMed ID: 34521330
[TBL] [Abstract][Full Text] [Related]
58. The Fragility of Statistically Significant Randomized Controlled Trials in Plastic Surgery.
Chin B; Copeland A; Gallo L; Wakeham S; Coroneos CJ; Walsh M; Thoma A; Voineskos S
Plast Reconstr Surg; 2019 Nov; 144(5):1238-1245. PubMed ID: 31688772
[TBL] [Abstract][Full Text] [Related]
59. The Continuous Fragility Index of Statistically Significant Findings in Randomized Controlled Trials That Compare Interventions for Anterior Shoulder Instability.
Al-Asadi M; Sherren M; Abdel Khalik H; Leroux T; Ayeni OR; Madden K; Khan M
Am J Sports Med; 2024 Jan; ():3635465231202522. PubMed ID: 38258495
[TBL] [Abstract][Full Text] [Related]
60. Application of the Reverse Fragility Index to Statistically Nonsignificant Randomized Clinical Trial Results.
Khan MS; Fonarow GC; Friede T; Lateef N; Khan SU; Anker SD; Harrell FE; Butler J
JAMA Netw Open; 2020 Aug; 3(8):e2012469. PubMed ID: 32756927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
